890 words · Editorial

What a Month of GLP-1 Actually Costs in Mid-2026 — the Real Numbers, With the Traps

The list price is fiction, the "$199" is an introductory rate, and one manufacturer's "$449 maintenance" turns into $699 if you refill four days late. Here is the real price of each major GLP-1 as of July 2026, with the conditions that move it.

Written byGLP1Zoom Editorial, Medical content team · Independent editorial

Medically reviewed byGLP1Zoom Editorial Team, Evidence-based editorial review Reviewed Jul 24, 2026

Published July 24, 2026

Key takeaways

Wegovy self-pay runs about $199/month for the first two fills and then about $349/month for maintenance; the oral pill starts around $149/month.
Ozempic self-pay is about $199/month for the first two fills, then $349/month at 0.25–1 mg and $499/month at 2 mg.
Zepbound climbs by dose: about $299/month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg and above only if you refill within 45 days — otherwise up to $699.
Missing the Zepbound 45-day refill window at maintenance doses costs about $250 more per month, buried in the purchase-offer terms.
Compounded semaglutide runs from about $69/month and compounded tirzepatide from about $99/month, neither FDA-approved.
With commercial insurance that covers the drug, a savings card can beat every cash price at as little as $25/month.

Nobody pays the list price of a GLP-1, so the list price tells you almost nothing. But the numbers that replace it in the headlines — "$199 a month," "$25 with a card," "$449 maintenance" — are each attached to a condition the headline drops. The result is that people budget for a number they'll never actually be charged. Here's the honest map as of mid-2026: what each drug really costs cash, and the specific trap sitting under each figure.

Every number below is a self-pay (cash) price unless noted, verified July 2026. Prices move — re-check before you commit.

Wegovy and Ozempic (semaglutide, Novo Nordisk)

Through the manufacturer's self-pay program:

Wegovy: about $199/month for the first two fills, then about $349/month for maintenance doses. The oral pill version starts around $149/month.
Ozempic: about $199/month for the first two fills, then $349/month (0.25/0.5/1 mg) or $499/month at the 2 mg dose.

The trap: the $199 is introductory — first two fills only. Budget off $199 for a year and you're short roughly $1,800, because your real ongoing cost is $349. Any source quoting "$199/mo" without the "first two fills" qualifier is quoting you an entry rate as if it were the standing price.

Zepbound (tirzepatide, Lilly)

Lilly's self-pay pricing, read from their own page, climbs steeply by dose:

$299/month at the 2.5 mg starting dose
$399/month at 5 mg
$449/month at 7.5 mg and up — but only if you refill within 45 days of your previous fill
$499–$699/month if you miss that 45-day window at the higher doses

The trap: that "$449 maintenance" price is conditional on refilling inside a 45-day window. Miss it on a 10–15 mg dose and the price jumps to $699 — a $250-a-month penalty for being late, buried in the purchase-offer terms. And note the 2.5 mg starter, where the cheapest number lives, is a starting dose nobody stays on. The range you'll actually face is $299 at the start climbing toward $449 (on schedule) or $699 (off schedule) at maintenance.

Mounjaro (tirzepatide, diabetes label)

Mounjaro's list price sits around $1,069/month, and its self-pay and coverage picture differs from Zepbound's despite being the identical molecule — because it's labeled for diabetes, not weight loss. This is the recurring theme: the label, not the molecule, drives the price and the coverage.

Compounded semaglutide and tirzepatide

Through telehealth compounding pharmacies:

Compounded semaglutide: about from about $69/month
Compounded tirzepatide: about from about $99/month

The trap: these are not FDA-approved, the shortages that justified mass-compounding ended in 2024–2025, and the product usually comes as a vial-and-syringe — which reintroduces the dosing-conversion risk the pens engineered away. The price is genuinely lower; what you give up is the FDA's manufacturing guarantee and, often, the safety of a pre-metered dose.

The two levers that beat all of these

The self-pay numbers above are the fallback. Two things beat them when they apply:

Commercial insurance + a savings card. If you have commercial insurance that covers the drug, a manufacturer savings card can drop your cost to as little as $25/month — far below any cash price. The catch: it's only that low if your plan covers the drug, it's barred on Medicare/Medicaid/TRICARE by law, and most cards expire December 31, 2026. The honest breakdown of which card does what is here for Wegovy.

New 2026 programs for the uninsured. The federal direct-purchase channel and a temporary $50/month Medicare bridge (July 2026–December 2027, and only for certain drugs) changed the floor for people with no coverage. They're narrower than the headlines — I mapped exactly who qualifies separately — but for the right person they beat every self-pay number above.

How to find your real number

Ignore the headline and ask four questions in order:

Am I commercially insured with coverage for this drug? If yes, a savings card is almost certainly your cheapest path — chase that first.
If not, what's the standing self-pay price at my maintenance dose? Not the intro price, not the starter dose. The number I'll pay in month six.
Does any discounted price depend on a refill window? (Zepbound's does.) If so, that's a calendar commitment, not just a price.
Am I on Medicare, or uninsured? That routes me to the bridge or the direct-purchase channel instead of the card.

The single sentence that saves the most money: the cheapest advertised number and the number you'll actually pay every month are almost never the same, and the whole gap lives in a condition the ad dropped. Find the condition, and you find your real price.

A plain-language walk-through of how GLP-1 pricing is structured — list vs cash vs card vs coverage — is here.

All prices verified July 2026 against manufacturer self-pay pages and program terms. These are moving numbers — confirm current pricing before you enroll or budget. General information, not medical or financial advice.

Common questions about What a Month of GLP-1 Actually Costs in Mid-2026 — the Real Numbers, With the Traps

How much does Wegovy cost per month without insurance?

Through the manufacturer self-pay program, about $199/month for the first two fills and then about $349/month for maintenance doses, verified July 2026. The oral semaglutide pill starts around $149/month. The introductory figure is not your ongoing cost — budgeting a year at $199 leaves you roughly $1,800 short.

How much does Zepbound cost per month?

Lilly self-pay pricing climbs with dose: about $299/month at the 2.5 mg starting dose, $399 at 5 mg, and $449 at 7.5 mg and above — but that maintenance price holds only if you purchase the refill within 45 days of the previous fill. Miss that window at 10–15 mg and the price is about $699/month.

What is the cheapest way to pay for a GLP-1 in 2026?

If you have commercial insurance that covers the drug, a manufacturer savings card is almost always cheapest, sometimes as little as $25/month. If you have no coverage, compare the manufacturer cash self-pay price at your maintenance dose against the 2026 direct-purchase and Medicare-bridge programs. Compounded is cheaper still but is not FDA-approved.

Compare the real monthly cost